Join Pillsbury partners David Tsai, Chris Kao and Josh Tucker for an engaging 30-minute conversation about what the COVID-19 crisis means for technology companies and their IP. Major topics include the current patent litigation climate, considerations for buying & selling IP portfolios, and a look ahead at the opportunities and implications of emerging tech.